Medications
Immunotherapy drug can beat back early-stage lung cancer
An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report.
May 20, 2021
0
5
Page 17 - News tagged with immune checkpoint inhibitor
Oncology & Cancer
Immunotherapy combination shows benefit for patients with advanced melanoma
A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a phase 3 clinical trial involving 714 patients. Dana-Farber ...
May 20, 2021
0
3
Oncology & Cancer
Researchers identify potential combination therapy for aggressive lung cancer
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to immunotherapy in people diagnosed with advanced lung cancer. ...
May 4, 2021
0
4
Oncology & Cancer
VTE risk high in cancer patients receiving immune checkpoint inhibitors
(HealthDay)—Patients with cancer receiving immune checkpoint inhibitor treatment are at high risk for thromboembolism, especially venous thromboembolism (VTE), according to a study published online March 25 in Blood.
Apr 26, 2021
0
5
Medications
Diabetes drug shows potential in fighting cancer
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents ...
Apr 14, 2021
0
15
Oncology & Cancer
Study reveals crucial details on skin-related side effects of cancer immune therapies
Immune checkpoint inhibitors, which boost the immune system's response against tumor cells, have transformed treatment for many advanced cancers, but short-term clinical trials and small observational studies have linked ...
Apr 12, 2021
0
0
Oncology & Cancer
Study reveals cancer immunotherapy patients at most risk of life-threatening side effects
Many patients with cancer receive immune checkpoint inhibitors that strengthen their immune response against tumor cells. While the medications can be life-saving, they can also cause potentially life-threatening side effects ...
Apr 12, 2021
0
48
Cardiology
High thrombotic risk in cancer patients receiving immunotherapy
In a study recently published in the leading journal Blood, Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in ...
Mar 31, 2021
0
13
Immunology
Lack of diversity in genomic databases may affect therapy selection for minority groups
Low representation of minority groups in public genomic databases may affect therapy selection for Black patients with cancer, according to new Mayo Clinic research published in npj Precision Oncology.
Mar 19, 2021
0
2
Oncology & Cancer
Study finds high tumor mutation burden predicts immunotherapy response in some, but not all, cancers
A high rate of genetic mutations within a tumor, known as high tumor mutation burden (TMB), was only useful for predicting clinical responses to immune checkpoint inhibitors in a subset of cancer types, according to a new ...
Mar 15, 2021
1
28
